EF
GSK icon

Exeter Financial’s GSK GSK Stock Holding History

Exeter Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,522
Closed -$221K – 85
2022
Q3 		$221K Sell
7,522
-27,710
-79% -$1.05M 0.13% 84
2022
Q2 		$1.92M Buy
35,232
+1,560
+5% +$86.1K 1.07% 40
2022
Q1 		$1.83M Buy
33,672
+3,325
+11% +$181K 0.99% 43
2021
Q4 		$1.7M Buy
30,347
+3,400
+13% +$177K 0.93% 42
2021
Q3 		$1.29M Sell
26,947
-45
-0.2% -$2.26K 0.77% 45
2021
Q2 		$1.36M Buy
26,992
+368
+1% +$17.7K 0.79% 47
2021
Q1 		$1.19M Buy
26,624
+852
+3% +$38.7K 0.75% 49
2020
Q4 		$1.19M Hold
25,772
– – 0.82% 46
2020
Q3 		$1.21M Buy
25,772
+80
+0.3% +$4.01K 0.95% 41
2020
Q2 		$1.31M Sell
25,692
-1,653
-6% -$84.8K 1.09% 35
2020
Q1 		$1.29M Buy
27,345
+1,887
+7% +$101K 1.22% 32
2019
Q4 		$1.5M Sell
25,458
-960
-4% -$53.4K 1.16% 37
2019
Q3 		$1.41M Hold
26,418
– – 1.12% 37
2019
Q2 		$1.32M Buy
26,418
+400
+2% +$20.1K 1.11% 40
2019
Q1 		$1.36M Sell
26,018
-636
-2% -$31.8K 1.18% 38
2018
Q4 		$1.27M Sell
26,654
-400
-1% -$19.7K 1.2% 36
2018
Q3 		$1.36M Buy
27,054
+81
+0.3% +$4.12K 1.12% 39
2018
Q2 		$1.36M Sell
26,973
-446
-2% -$22.5K 1.2% 33
2018
Q1 		$1.34M Buy
27,419
+7,861
+40% +$366K 1.15% 36
2017
Q4 		$867K Buy
+19,558
New +$904K 0.76% 52

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Exeter Financial's GSK Position: Q4 2022 in Review

Exeter Financial sold out of GSK (GSK) in Q4 2022, closing a stake of 7,522 shares — an estimated $221K sold.

Exeter Financial first reported a position in GSK in Q4 2017 and held it in 20 quarters. The position peaked at $1.92M in Q2 2022. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Exeter Financial reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Exeter Financial sold 7,522 GSK shares in Q4 2022, an estimated $221K.
  • Exeter Financial first reported a position in GSK in Q4 2017 and held it in 20 quarters.
  • Exeter Financial's GSK position peaked at $1.92M in Q2 2022.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Exeter Financial's 13F filing for Q4 2022, filed 24 Jan 2023.